Literature DB >> 16820138

Development of cellular immune responses to Plasmodium falciparum blood stage antigens from birth to 36 months of age in Cameroon.

Jean-Yves Le Hesran1, Nadine Fiévet, Jean Thioulouse, Philippe Personne, Bertrand Maubert, Samuel M'bidias, Daniel Etye'ale, Michel Cot, Philippe Deloron.   

Abstract

Naturally acquired immunity to Plasmodium falciparum is related to immune system that changes during normal development and ageing. The effects of repeated infections during the early life on the maturation of the immune system are still unknown. Elucidation of these effects is of considerable interest given that malaria originates high mortality, especially during the first years of life. We conducted a cohort study to identify naturally acquired immune responses to P. falciparum. Cellular responses of Cameroonian neonates from birth to 36 months of age were evaluated every 6 months by cell proliferation and cytokines (IFN-gamma, IL-2 and IL-4) production after in vitro culture in the presence of schizont extract and Pf155/RESA peptides. Data were analyzed by a multiple correspondence analysis (MCA) exhibiting three main findings. Firstly, the lack of time-dependant evolution of specific immune pathways recruitment in the response to a given antigen, no antigen inducing a specific mode of response at a given time-point. Secondly, most of the data variability was expressed by IFN-gamma and IL-4 productions, and the major variation of the immune response with age involved this change in IFN-gamma production. Thirdly, the age-related immune response evolution is characterized by the acquisition of the capacity to mount a IFN-gamma response, a transient phase during which children produce a high IL-4 response, and the fast vanishing of the dominance of the IL-2 response. These results suggest that P. falciparum specific immune responses are first oriented towards a Th2-type of response, and later switch to Th1-type of response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820138     DOI: 10.1016/j.actatropica.2006.05.010

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  7 in total

1.  Our impasse in developing a malaria vaccine.

Authors:  Michael F Good
Journal:  Cell Mol Life Sci       Date:  2011-02-15       Impact factor: 9.261

2.  A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical Malaria.

Authors:  Carlota Dobaño; Augusto J Nhabomba; Maria N Manaca; Tamara Berthoud; Ruth Aguilar; Llorenç Quintó; Arnoldo Barbosa; Mauricio H Rodríguez; Alfons Jiménez; Penny L Groves; Rebeca Santano; Quique Bassat; John J Aponte; Caterina Guinovart; Denise L Doolan; Pedro L Alonso
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

3.  Developmental allometry and paediatric malaria.

Authors:  Erica M W Billig; Wendy P O'Meara; Eleanor M Riley; F Ellis McKenzie
Journal:  Malar J       Date:  2012-03-06       Impact factor: 2.979

4.  Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.

Authors:  Diana Quelhas; Laura Puyol; Llorenç Quintó; Tacilta Nhampossa; Elisa Serra-Casas; Eusébio Macete; Pedro Aide; Sergi Sanz; John J Aponte; Denise L Doolan; Pedro L Alonso; Clara Menéndez; Carlota Dobaño
Journal:  BMC Immunol       Date:  2012-01-26       Impact factor: 3.615

5.  Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.

Authors:  María Rupérez; Raquel González; Ghyslain Mombo-Ngoma; Abdunoor M Kabanywanyi; Esperança Sevene; Smaïla Ouédraogo; Mwaka A Kakolwa; Anifa Vala; Manfred Accrombessi; Valérie Briand; John J Aponte; Rella Manego Zoleko; Ayôla A Adegnika; Michel Cot; Peter G Kremsner; Achille Massougbodji; Salim Abdulla; Michael Ramharter; Eusébio Macete; Clara Menéndez
Journal:  PLoS Med       Date:  2016-02-23       Impact factor: 11.069

6.  Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.

Authors:  Arlene E Dent; Kiprotich Chelimo; Peter O Sumba; Michele D Spring; Brendan S Crabb; Ann M Moormann; Daniel J Tisch; James W Kazura
Journal:  Malar J       Date:  2009-07-16       Impact factor: 2.979

Review 7.  Mefloquine safety and tolerability in pregnancy: a systematic literature review.

Authors:  Raquel González; Urban Hellgren; Brian Greenwood; Clara Menéndez
Journal:  Malar J       Date:  2014-02-28       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.